CLINIQUE FOR MEN UV DEFENSE BROAD SPECTRUM SPF50

Manufacturer: CLINIQUE LABORATORIES LLC | ESTEE LAUDER COMPANY, THE | ESTEE LAUDER COSMETICS, LTD | ESTEE LAUDER COSMETICS, LTD. | ESTEE LAUDER N.V. | LEN-RON MANUFACTURING DIVISION OF ARAMIS INC | NORTHTEC INC | PADC 1 | WHITMAN LABORATORIES, LTD.
Effective date: 2019-11-15
Label type: HUMAN OTC DRUG LABEL
Version: 3
Source: legacy-cache
Hydrated at: 2026-08-02 00:01:07

Label at a glance#

ProductCLINIQUE FOR MEN UV DEFENSE BROAD SPECTRUM SPF50

Active ingredienttitanium dioxide, zinc oxide

Label structure9 sections

Dosage and administration

For sunscreen use: apply liberally 15 minutes before sun exposure reapply at least every two hours use a water resistant sunscreen if swimming or sweating Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in...

Storage and handling

Protect the product in this container from excessive heat and direct sun

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Titanium dioxide 6.2%
Zinc oxide 4.0%

Purpose

OTC - PURPOSE SECTION

Sunscreen

Use

INDICATIONS & USAGE SECTION

helps prevent sunburn

Warnings

WARNINGS SECTION

For external use only

OTC - DO NOT USE SECTION

Do not use on damaged or broken skin

OTC - WHEN USING SECTION

When using this product keep out of eyes. Rinse with water to remove.

OTC - STOP USE SECTION

Stop use and ask a doctor if rash occurs

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

For sunscreen use:

apply liberally 15 minutes before sun exposure
reapply at least every two hours
use a water resistant sunscreen if swimming or sweating
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m.–2 p.m.
- wear long-sleeved shirts, pants, hats and sunglasses.
children under 6 months of age: ask a doctor

Inactive ingredients

INACTIVE INGREDIENT SECTION

water\aqua\eau•dimethicone•butyloctyl salicylate•polydiethyl siloxane•c12-15 alkyl benzoate•isononyl isononanoate•diethylhexyl succinate•neopentyl glycol diheptanoate•methyl trimethicone•butylene glycol•ethylhexyl methoxycrylene•lauryl peg-9 polydimethylsiloxyethyl dimethicone•silica•laureth-4•cetyl peg/ppg-10/1 dimethicone•dipentaerythrityl tri-polyhydroxystearate•dimethicone silylate•hydrolyzed wheat protein/pvp crosspolymer•isostearic acid•caprylyl glycol•dimethicone crosspolymer-3•polyhydroxystearic acid•triethoxycaprylylsilane•dimethicone/peg-10/15 crosspolymer•dipropylene glycol•phenoxyethanol•iron oxides (ci 77491)•iron oxides (ci 77492) [iln41056]

Other information

STORAGE AND HANDLING SECTION

Protect the product in this container from excessive heat and direct sun

PRINCIPAL DISPLAY PANEL - 30 ml Bottle Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

CLINIQUE
FOR MEN

UV defense
broad spectrum
SPF 50

1 FL.OZ.LIQ./30 ml e

Principal Display Panel - 30 ml Bottle Carton

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
titanium dioxide	ACTIVE INGREDIENT	15FIX9V2JP	1
zinc oxide	ACTIVE INGREDIENT	SOI2LOH54Z	1
titanium dioxide	ACTIVE MOIETY	15FIX9V2JP	1
zinc oxide	ACTIVE MOIETY	SOI2LOH54Z	1
alkyl (c12-15) benzoate	INACTIVE INGREDIENT	A9EJ3J61HQ	1
butylene glycol	INACTIVE INGREDIENT	3XUS85K0RA	1
butyloctyl salicylate	INACTIVE INGREDIENT	2EH13UN8D3	1
caprylyl glycol	INACTIVE INGREDIENT	00YIU5438U	1
diethylhexyl succinate	INACTIVE INGREDIENT	69W9UMG3P8	1
dimethicone	INACTIVE INGREDIENT	92RU3N3Y1O	1
dipropylene glycol	INACTIVE INGREDIENT	E107L85C40	1
ethylhexyl methoxycrylene	INACTIVE INGREDIENT	S3KFG6Q5X8	1
ferric oxide red	INACTIVE INGREDIENT	1K09F3G675	1
ferric oxide yellow	INACTIVE INGREDIENT	EX438O2MRT	1
isononyl isononanoate	INACTIVE INGREDIENT	S4V5BS6GCX	1
isostearic acid	INACTIVE INGREDIENT	X33R8U0062	1
laureth-4	INACTIVE INGREDIENT	6HQ855798J	1
lauryl peg-9 polydimethylsiloxyethyl dimethicone	INACTIVE INGREDIENT	25G622K2RA	1
methyl trimethicone	INACTIVE INGREDIENT	S73ZQI0GXM	1
neopentyl glycol diheptanoate	INACTIVE INGREDIENT	5LKW3C543X	1
phenoxyethanol	INACTIVE INGREDIENT	HIE492ZZ3T	1
silicon dioxide	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
triethoxycaprylylsilane	INACTIVE INGREDIENT	LDC331P08E	1
water	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 24 matching rows.

CLINIQUE FOR MEN UV DEFENSE BROAD SPECTRUM SPF50
titanium dioxide and zinc oxide
titanium dioxide
zinc oxide
water
dimethicone
butyloctyl salicylate
alkyl (c12-15) benzoate
isononyl isononanoate
diethylhexyl succinate
neopentyl glycol diheptanoate
methyl trimethicone
butylene glycol
ethylhexyl methoxycrylene
lauryl peg-9 polydimethylsiloxyethyl dimethicone
silicon dioxide
laureth-4
isostearic acid
caprylyl glycol
triethoxycaprylylsilane
dipropylene glycol
phenoxyethanol
ferric oxide red
ferric oxide yellow

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
49527-046	49527-046-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 22 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
titanium dioxide	15FIX9V2JP	ACTIB
zinc oxide	SOI2LOH54Z	ACTIB
water	059QF0KO0R	IACT
dimethicone	92RU3N3Y1O	IACT
butyloctyl salicylate	2EH13UN8D3	IACT
alkyl (c12-15) benzoate	A9EJ3J61HQ	IACT
isononyl isononanoate	S4V5BS6GCX	IACT
diethylhexyl succinate	69W9UMG3P8	IACT
neopentyl glycol diheptanoate	5LKW3C543X	IACT
methyl trimethicone	S73ZQI0GXM	IACT
butylene glycol	3XUS85K0RA	IACT
ethylhexyl methoxycrylene	S3KFG6Q5X8	IACT
lauryl peg-9 polydimethylsiloxyethyl dimethicone	25G622K2RA	IACT
silicon dioxide	ETJ7Z6XBU4	IACT
laureth-4	6HQ855798J	IACT
isostearic acid	X33R8U0062	IACT
caprylyl glycol	00YIU5438U	IACT
triethoxycaprylylsilane	LDC331P08E	IACT
dipropylene glycol	E107L85C40	IACT
phenoxyethanol	HIE492ZZ3T	IACT
ferric oxide red	1K09F3G675	IACT
ferric oxide yellow	EX438O2MRT	IACT

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 108 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	DROPS / ORAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	TABLET / SUBLINGUAL	1 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, EXTENDED RELEASE / ORAL		450 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / SUBLINGUAL		10 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	FILM, EXTENDED RELEASE / TRANSDERMAL	49 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CREAM / VAGINAL		51 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	PELLET / ORAL		34 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, LIQUID FILLED / ORAL		106 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	CAPSULE / ORAL		14 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FILM COATED / ORAL		166 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, COATED / ORAL		1 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	SUSPENSION, EXTENDED RELEASE / ORAL	2.7 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, FILM COATED / ORAL		6 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
phenoxyethanol	PHENOXYETHANOL	HIE492ZZ3T	CREAM, AUGMENTED / TOPICAL		10 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	GRANULE, DELAYED RELEASE / ORAL	3.2 mg		Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER / ORAL		602 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, EXTENDED RELEASE / ORAL		168 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
phenoxyethanol	PHENOXYETHANOL	HIE492ZZ3T	LOTION / TOPICAL	1 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	POWDER, FOR SUSPENSION / ORAL		2553 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
laureth-4	LAURETH-4	6HQ855798J	GEL / TOPICAL		60 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, COATED / ORAL		3 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		336 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	TABLET, DELAYED RELEASE / ORAL		37 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL		68 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, COATED PELLETS / ORAL		69 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	CREAM / TOPICAL	NA		Exact identifier — unii candidate 21 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	POWDER / RESPIRATORY (INHALATION)	0.04 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET / ORAL		24 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
dipropylene glycol	DIPROPYLENE GLYCOL	E107L85C40	SYSTEM / TRANSDERMAL		6 mg	Exact identifier — unii candidate 3 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, COATED / ORAL		176 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	TABLET, COATED / ORAL	1 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, DELAYED RELEASE / ORAL		1190 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE, DELAYED RELEASE / ORAL		40 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, DELAYED RELEASE / ORAL		7 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	CAPSULE / ORAL		5 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
laureth-4	LAURETH-4	6HQ855798J	SOLUTION / TOPICAL	5.22 %w/v		Exact identifier — unii candidate 4 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	GRANULE, FOR SUSPENSION / ORAL		11 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
isostearic acid	ISOSTEARIC ACID	X33R8U0062	CREAM / TOPICAL		100 mg	Exact identifier — unii candidate 3 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	CAPSULE, DELAYED RELEASE / ORAL		14 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
isostearic acid	ISOSTEARIC ACID	X33R8U0062	GEL / TOPICAL		20 mg	Exact identifier — unii candidate 3 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET / BUCCAL		3 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
dipropylene glycol	DIPROPYLENE GLYCOL	E107L85C40	FILM, EXTENDED RELEASE / TRANSDERMAL		296 mg	Exact identifier — unii candidate 3 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	SUSPENSION / ORAL		6 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
dipropylene glycol	DIPROPYLENE GLYCOL	E107L85C40	FILM, EXTENDED RELEASE / BUCCAL		30 mg	Exact identifier — unii candidate 3 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	POWDER, FOR SUSPENSION / ORAL		3 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, CHEWABLE / ORAL		254 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	SOLUTION / ORAL		336 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET / SUBLINGUAL	1 mg		Exact identifier — unii candidate 20 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	INSERT / VAGINAL		8 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, EXTENDED RELEASE / ORAL		15 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	PASTE / DENTAL	34 %w/w		Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	CAPSULE / ORAL		300 mg	Exact identifier — unii candidate 49 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	GEL / DENTAL	19 %w/w		Exact identifier — unii candidate 49 equally ranked IID candidates
ferric oxide yellow	FERRIC OXIDE YELLOW	EX438O2MRT	TABLET, CHEWABLE / ORAL		14 mg	Exact identifier — unii candidate 20 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	TABLET / ORAL		8 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	DROPS / ORAL	NA		Exact identifier — unii candidate 21 equally ranked IID candidates
ferric oxide red	FERRIC OXIDE RED	1K09F3G675	TABLET, CHEWABLE / ORAL		2 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
silicon dioxide	SILICON DIOXIDE	ETJ7Z6XBU4	TAMPON / VAGINAL	NA		Exact identifier — unii candidate 49 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
24ef46d7-6d56-4544-88c1-ee5cb8e5d5f4			d1b76faa-c191-4c8e-aeac-56263a628c10	2021-07-19	Warnings	Exact identifier spl set id: d1b76faa-c191-4c8e-aeac-56263a628c10

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.